A white crystalline compound used in the treatment of muscle fatigue myasthenia and to reverse the effects of muscle relaxant drugs.
Cholinergic drug used to treat myasthenia gravis. Adverse effects include intestinal pain and cramping, excess salivation, and respiratory depression.
A parasympathomimetic drug that acts by inhibiting the enzyme cholinesterase. It is used mainly to diagnose and treat myasthenia gravis and as an antidote to some muscle-relaxant drugs, such as tubocurarine. It is also used to treat some intestinal disorders and glaucoma. Neostigmine is administered by mouth, injection, or in eye-drops; side-effects include digestive upsets and increased saliva flow.
An anticholinestetrase drug used to treat myasthenia gravis. It enhances neuromuscular transmission the passage of chemical messages between nerve and muscle cells in voluntary and involuntary muscles for about 4 hours.
Neostigmine is a medication employed to manage myasthenia gravis, an uncommon autoimmune condition leading to muscle weakness. This drug enhances the functionality of acetylcholine, a neurotransmitter responsible for triggering muscle contractions, released from nerve endings.
Potential adverse effects associated with neostigmine encompass nausea, vomiting, heightened salivation, diarrhea, abdominal cramps, blurred vision, muscle cramps, sweating, and muscular twitching.